CardioNet

Conshohocken, United States Founded: 1999 • Age: 27 yrs Listed
Outpatient cardiac arrhythmia monitoring solutions are provided by CardioNet.

About CardioNet

CardioNet is a publicly listed company based in Conshohocken (United States) founded in 1999. Outpatient cardiac arrhythmia monitoring solutions are provided by CardioNet. It operates in the Healthcare and Technology sectors. CardioNet has raised $141.9 million across 6 funding rounds from investors including IDEO, Tekla Capital Management and Guidant. CardioNet has completed 3 acquisitions, including Biomedical Systems, Cardiocore and Ecgscanning. CardioNet offers products and services including MCOT, ePatch, Implantable Device Monitoring, and Telehealth. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is BioTelemetry, Inc. Its competitors include Edwards Lifesciences, BioIntelliSense and Endotronix; 2 of its 3 listed competitors have raised funding.

Company details

CardioNet was founded in 1999 and is based in Conshohocken, United States. Operations center on the healthcare sector, specifically the diagnosis and monitoring of cardiac arrhythmias. Services include Mobile Cardiac Outpatient Telemetry (MCOT), event monitoring, and Holter monitoring. MCOT utilizes a lightweight, patient-worn sensor attached to electrodes to capture two-channel ECG data, tracking heart electrical activity in outpatient settings.

  • Headquarters Conshohocken, United States
  • Stage Public
  • Sectors
    Healthcare
    Technology
  • Website cardionet.com
  • Social LinkedIn X YouTube
  • Legal Name Biotelemetry, Inc.
Key Metrics
  • Total Equity Funding
    $141.9M (USD)

    in 6 rounds

  • Latest Funding Round
    $6.9M (USD), Post-IPO

    Apr 2021

  • Investors
    IDEO

    & 5 more

  • Investments & Acquisitions

Products & Services of CardioNet

CardioNet offers a comprehensive portfolio of products and services, including MCOT, ePatch, Implantable Device Monitoring, and Telehealth.

MCOT
Cardiac Telemetry

Mobile system for detecting and reporting arrhythmias remotely.

ePatch
Extended Holter Monitoring

Wearable device for prolonged ECG recording and analysis.

Implantable Device Monitoring
Remote Device Management

System for tracking implanted cardiac devices from afar.

Telehealth
Virtual Care Platform

Platform enabling remote consultations and patient support.

Apps and channels of CardioNet

its YouTube channel Philips Ambulatory Monitoring and Diagnostics has 1.84K subscribers and 30 videos.

Philips Ambulatory Monitoring and Diagnostics
YouTube 1.84K subscribers 30 videos Howto & Style
Open channel

Videos from CardioNet

The most watched videos on CardioNet's YouTube channel, Philips Ambulatory Monitoring and Diagnostics (1.84K subscribers). Click a video to play it here.

Philips Mobile Cardiac Telemetry – MCOT patch patient education video
135.7K views
Philips Mobile Cardiac Telemetry – MCOT patch Maintenance tips for patients
43.2K views
Philips Extended Holter – ePatch patient education video
37.5K views
Philips Mobile Cardiac Telemetry – MCOT Lead wire adapter patient education video
18.5K views

More on Philips Ambulatory Monitoring and Diagnostics.

Funding Insights of CardioNet

CardioNet has successfully raised a total of $141.9M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.9 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $141.9M
  • Total Rounds 6
  • Last Round Post-IPO β€” $6.9M
  • First Round $13M

    (Jan 2003)

  • Investors Count 6

All 6 funding rounds of CardioNet with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2021$6.9MPost-IPO––
Mar 2007$110MSeries D––
–
Aug 2005$3.9MSeries C––
–
Apr 2004$10MSeries C––
–
Apr 2003$5MSeries C––
–
Jan 2003$13MSeries C––
Valuation history

6 investors in total: 6 institutional.

Investors in CardioNet

CardioNet has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include IDEO, Tekla Capital Management and Guidant.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
inglewoodventures.com
Biomedical investment financing and active management services.
sanderling.com
Support is provided for life science ventures by BioFrontier.
2001biofrontier.co.jpTokyo, Japan
Human-centered design and innovation consulting is provided to organizations.
1991ideo.comPalo Alto, United States
Investment advisory services are provided to financial clients.
1986teklacap.comBoston, United States
Limited information available
1994guidant.comMarlborough, United States
Premium access

Investor details for CardioNet

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of CardioNet

CardioNet is a publicly listed company on the NASDAQ with ticker symbol BEAT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date02 Aug 2013
  • Listed onNASDAQ: BEAT
  • Listed entityHeartbeam, Inc.
  • Exchange sectorHealth technology

Investments & Acquisitions by CardioNet

CardioNet has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Biomedical Systems, Cardiocore and Ecgscanning.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of specialized clinical trial services like cardiac safety testing, imaging and eCOA related services
biomedsys.comSt. Louis, United States1975Mar 2014$8.65M
Cardiac core lab services including ECG and echocardiography are provided.
cardiocore.comRockville, United States1992Aug 2012$23.5M
ECG scanning services are provided by Ecgscanning.
ecgscanning.com0Feb 2012$5.8M
Premium access

Complete acquisition details for CardioNet

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of CardioNet

7 dated milestones of CardioNet across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded CardioNet is founded.
  2. Funding First funding round of $13.0M.
  3. Acquisition Acquires Ecgscanning.
  4. Acquisition Acquires Cardiocore.
  5. IPO Lists on the stock exchange (IPO).
  6. Acquisition Acquires Biomedical Systems.
  7. Funding Latest funding round, Post-IPO, of $6.9M.

Competitors of CardioNet

CardioNet has 3 listed competitors in our database, 2 of them funded. They include Edwards Lifesciences, BioIntelliSense and Endotronix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
edwards.com1958Irvine, United States19,800
Medical devices for structural heart disease are developed and provided.
biointellisense.com2018Redwood, United States$82M26
Vital signs are monitored via a single-use patch and platform.
endotronix.com2007East Peoria, United States$154.77M104
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
Premium access

Detailed competitors of CardioNet

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CardioNet

Websites that share an audience with CardioNet (cardionet.com).

Similar websites

Websites whose visitors overlap most with CardioNet. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cordis.com
100%
44.3K#735,879View details
smith-nephew.com
100%
296.7K#152,630View details
bd.com
100%
1.2M#57,463View details
owens-minor.com
100%
64.7K#417,011View details
stryker.com
100%
1.1M#56,352View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 29 similar websites and full traffic analytics for CardioNet

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 29 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as CardioNet (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cardionet

Premium access

Complete news archive for CardioNet

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CardioNet

CardioNet was founded in 1999 and raised its 1st funding round 4 years after it was founded.

CardioNet is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.

CardioNet is a funded company, having raised a total of $141.9M across 6 funding rounds to date. The company's 1st funding round was a Series C of $13M, raised on Jan 2003.

CardioNet was founded in 1999 and is based in Conshohocken, United States. Operations center on the healthcare sector, specifically the diagnosis and monitoring of cardiac arrhythmias. Services include Mobile Cardiac Outpatient Telemetry (MCOT), event monitoring, and Holter monitoring. MCOT utilizes a lightweight, patient-worn sensor attached to electrodes to capture two-channel ECG data, tracking heart electrical activity in outpatient settings.

CardioNet's top competitors include Endotronix, BioIntelliSense and Edwards Lifesciences.

CardioNet offers MCOT, ePatch, Implantable Device Monitoring, and Telehealth.

Yes, CardioNet is publicly traded on NASDAQ under the ticker symbol BEAT.

CardioNet has made 3 acquisitions, including Biomedical Systems, Cardiocore, and Ecgscanning.

CardioNet has 6 investors. Key investors include IDEO, Tekla Capital Management, Guidant, IngleWood Ventures, and Sanderling Ventures.

CardioNet operates through Biotelemetry, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available